Aptar continues enlargement with extra pharma plant alike Mumbai, Republic of India
Crystal Pond, Illinois, November 13, 2024, – AptarGroup, Inc., a world chief in drug and shopper product dosing, dishing out and coverage applied sciences, lately introduced the groundbreaking rite of its pristine pharma plant in Taloja, Republic of India, alike Mumbai. The ability will backup Aptar proceed to satisfy the rising calls for of the pharmaceutical trade in Republic of India.
Sanjay Kapote, President of Aptar Pharma Republic of India and Southeast Asia, commented, “Over the past decade, Aptar Pharma has achieved strong and consistent growth, thanks to our reliable products, regulatory expertise and knowledge of patient needs. This additional plant in Taloja will further strengthen our ability to efficiently deliver high-quality, innovative products and reinforces our commitment to investing in the pharma end markets. Additionally, we are keen on exploring acquisitions in the pharma space. We see significant growth potential within the pharmaceutical industry in India and the potential to expand our position in the market.”
The pristine cutting-edge facility will extend the corporate’s present footprint within the patch generation including extra native manufacturing of a number of applied sciences together with Aptar’s pressurized metered-dose inhaler (pMDI) valve, in addition to breath-actuated units and single-dose nasal sprays.
The pristine Taloja plant can even allow Aptar to satisfy the patch’s rising wishes via including an extra 4400 m2 of producing footprint and shall be built adjoining to the prevailing Aptar Mumbai facility that opened in 2023.
Aptar is dedicated to good for one its roots within the patch thru each natural enlargement and strategic acquisitions. The corporate appears for attainable acquisitions and partnerships with IP pushed, pharma packaging firms to proceed the growth in their drug dosing, dishing out and coverage choices.
About Aptar
Aptar is a world chief in drug and shopper product dosing, dishing out and coverage applied sciences. Aptar serves numerous horny finish markets together with pharmaceutical, good looks, meals, beverage, non-public assist and residential assist. The usage of marketplace experience, proprietary design, engineering and science to form cutting edge answers for lots of the international’s eminent manufacturers, Aptar in flip makes a significant residue within the lives, appears, fitness and houses of thousands and thousands of sufferers and customers around the globe. Aptar is headquartered in Crystal Pond, Illinois and has over 13,000 devoted staff in 20 international locations. For more info, seek advice from www.aptar.com.
This press let go comprises forward-looking statements. Ahead-looking statements usually can also be known via the truth that they don’t relate strictly to ancient or flow details and via worth of phrases corresponding to “expects,” “anticipates,” “believes,” “estimates,” “future,” “potential,” “continues” and alternative homogeneous expressions or generation or conditional verbs corresponding to “will,” “should,” “would” and “could” are supposed to spot such forward-looking statements. Ahead-looking statements are made pursuant to the preserve harbor provisions of Division 27A of the Securities Function of 1933 and Division 21E of the Securities Alternate Function of 1934 and are in accordance with our ideals in addition to suppositions made via and knowledge these days to be had to us. Accordingly, our unedited effects or alternative occasions would possibly fluctuate materially from the ones expressed or implied in such forward-looking statements because of identified or unknown dangers and uncertainties that exist in our operations and industry surrounding together with, however no longer restricted to: the a hit integration of acquisitions; the regulatory surrounding; and festival, together with technological advances. For extra data on those and alternative dangers and uncertainties, refer to our filings with the Securities and Alternate Fee, together with the dialogue below “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our Mode 10-Ok and Methods 10-Q. We adopt deny legal responsibility to replace publicly any forward-looking statements, whether or not on account of pristine data, generation occasions or in a different way, except for as in a different way required via regulation.
Aptar Investor Family members Touch:
Mary Skafidas
mary.skafidas@aptar.com
+1 347 351 6407
Aptar Media Touch
Katie Reardon
katie.reardon@aptar.com
+1 815 479 5671
For additional media queries, please touch:
Sonia Kulkarni, Hunk Blonde and Media
Cell: 9820184099 | E mail: sonia.kulkarni@hunkgolden.in
+ There are no comments
Add yours